| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 7 |
| 1 | PREDNISOLONE | 5 |
| 2 | PREDNISOLONE ORAL | 5 |
| 3 | PREDNISOLONE ORAL SOLUTION | 5 |
| 4 | MYCOPHENOLATE MOFETIL | 4 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 4 |
| 6 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 |
| 7 | DAPTOMYCIN | 2 |
| 8 | TOFACITINIB | 2 |
| 9 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXACILLIN SODIUM | 1 | 0.0009 |
| 1 | EPINASTINE HYDROCHLORIDE | 1 | 0.0009 |
| 2 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 4 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| 5 | DAPTOMYCIN | 2 | 0.0002 |
| 6 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 7 | MICAFUNGIN SODIUM | 1 | 0.0002 |
| 8 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 14 |
| 1 | Lipopeptide Antibacterial [EPC] | 2 |
| 2 | Alkylating Drug [EPC] | 1 |
| 3 | Aluminum Complex [EPC] | 1 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 5 | Antimalarial [EPC] | 1 |
| 6 | Antiprotozoal [EPC] | 1 |
| 7 | Aromatase Inhibitor [EPC] | 1 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 |
| 9 | Benzodiazepine [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 2 | Lipopeptide Antibacterial [EPC] | 2 | 0.0002 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 5 | Antimalarial [EPC] | 1 | 0.0001 |
| 6 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 9 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |